PAT www.europeanpharmaceuticalreview.com


SUPPLEMENT Issue 6 2011


The FDA’s PAT Initiative, past and present


Examples from the Novartis experience


Adopting a multidisciplinary approach


Find out how vendor companies are answering the PAT industry’s needs in our Leaders Roundtable


SPONSORS


TO READ MORE FROM OUR SPONSORS, CLICK ON THEIR LOGO


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17